Yüklüyor......
Striving for optimal bronchodilation: focus on olodaterol
β(2)-agonists were introduced in the 1940s as bronchodilators to be used in obstructive respiratory diseases. Long-acting β(2)-agonists have been a mainstay of bronchodilating treatment for decades. Recently, agents extending their effect to 24 hours and thus allowing the once-daily administration w...
Kaydedildi:
| Yayımlandı: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780202/ https://ncbi.nlm.nih.gov/pubmed/27042036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S96070 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|